Hikma expands nasal spray capabilities12 Aug 2019
Company acquires unit-dose nasal and sublingual spray manufacturing equipment, as well as two pipeline products.
Hikma Pharmaceuticals has signed an asset purchase agreement with Insys Therapeutics to acquire a complementary manufacturing platform and two pipeline products.
In June 2019, Insys filed petitions seeking relief under Chapter 11 of the US Bankruptcy Code. As part of this process, Insys initiated a court-supervised process to sell its assets. This process has now concluded with respect to certain assets, and Hikma has agreed to acquire unit-dose nasal and sublingual spray manufacturing equipment, as well as two pipeline products, naloxone 505(b)2 nasal spray and epinephrine 505(b)2 nasal spray.
Naloxone is a medication used to block or reverse the effect of opioids. Narcan is the only nasal form of naloxone on the market. According to IQVIA, US sales of Narcan were approximately $164 million in the 12 months ending June 2019.
Epinephrine is a medication used to treat a number of conditions, including anaphylaxis, cardiac arrest, and superficial bleeding. According to IQVIA, US sales of epinephrine auto-injectors were approximately $4.3 billion in the 12 months ending June 2019. There are no currently approved nasal forms of epinephrine in the US.
Brian Hoffmann, President of Generics, stated: "Hikma is the largest supplier of generic nasal sprays in the US and we have been looking for ways to build upon our strong manufacturing platform and expand our product portfolio. This acquisition adds unit-dose nasal spray manufacturing equipment, as well as two complex products to our pipeline. This new technology expands our existing nasal spray capabilities, creating a comprehensive platform, which we can leverage for both internal and partnership programmes."
Funding to accelerate delivery of Univercells' vaccine portfolio
11 Oct 2019
European financing to support Univercells’ R&D investments to develop four essential and undersupplied global health vaccines to be produced at affordable prices, high quality and large volumes.Read more
Industrial-scale manufacture of therapeutic exosomes
10 Oct 2019
Coordinated purification process development service accelerates progress to clinical trials, and scale-up manufacturing.Read more
Janssen opens new biomanufacturing building in Ireland
8 Oct 2019
Expansion creates 200 new full-time jobs and increases the company’s production capacity by an additional 19,100 m2.Read more
BASF and Biomillenia join forces in microbiome research to promote healthy skin
7 Oct 2019
Research aims to identify novel dermocosmetic active ingredients via unique microbiome-on-a-chip technology.Read more
Allergan expands Refresh eye treatment portfolio
7 Oct 2019
A trifecta of relief formulated with HydroCell technology offers new artificial tear options for patients suffering from eye dryness.Read more
BASF strengthens biotechnology footprint to enter natural F&F ingredients market
3 Oct 2019
Market entrance with biotech-based natural vanillin, valencene and nootkatone.Read more
Unidose device approved for Tosymra sumatriptan spray
3 Oct 2019
Provides migraine sufferers with a convenient, patient-friendly delivery approach.Read more
One-stop-platform for plant-based nutraceuticals
2 Oct 2019
In 2020, nutra brands will look to ensure they have plant-based options across all product classes with many actively looking to move entire portfolios plant-based.Read more
BASF's new bioactive ingredient the wellness elixir for healthy skin
1 Oct 2019
The active ingredient is a 100% natural extract from the chaga mushroom, obtained using an innovative eco-friendly technology: subcritical water extraction.Read more
Arctoris secures funding to advance novel robotic drug discovery platform
1 Oct 2019
Platform will enable scientists and biotechnology entrepreneurs worldwide to make discoveries faster and more efficiently,Read more
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation